Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harry

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|May 4, 2021
Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry studyFatma E El-Khouly, Syed M Adil, Maria Wiese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2013
Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patientsDerrek A Heuveling, Annelies van Schie, Danielle J Vugts, et al.
Frontiers in Pharmacology|June 3, 2016
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?Yvonne W S Jauw, C Willemien Menke-van der Houven van Oordt, Otto S Hoekstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
The Role of <sup>89</sup>Zr-Immuno-PET in Navigating and Derisking the Development of BiopharmaceuticalsGuus A M S van Dongen, Wissam Beaino, Albert D Windhorst, et al.
British Journal of Pharmacology|June 14, 2005
New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kineticsJoost Bart, Eli C F Dijkers, Theodora D Wegman, et al.
Acta Oncologica (Stockholm, Sweden)|March 26, 2019
Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patientsChristel C L M Boons, Vashti N M F Tromp, Nienke J M Neppelenbroek, et al.
Nuklearmedizin. Nuclear Medicine|July 23, 2016
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world studyRogier Lange, Floor Overbeek, John M H de Klerk, et al.
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital settingG Luurtsema, R Boellaard, H N J M Greuter, et al.
Journal of Neuro-Oncology|May 8, 2021
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine gliomaFatma E El-Khouly, Sophie E M Veldhuijzen van Zanten, Marc H A Jansen, et al.
EJNMMI Research|March 30, 2012
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoproteinFemke E Froklage, Stina Syvänen, N Harry Hendrikse, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|May 4, 2021
Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry studyFatma E El-Khouly, Syed M Adil, Maria Wiese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2013
Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patientsDerrek A Heuveling, Annelies van Schie, Danielle J Vugts, et al.
Frontiers in Pharmacology|June 3, 2016
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?Yvonne W S Jauw, C Willemien Menke-van der Houven van Oordt, Otto S Hoekstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
The Role of <sup>89</sup>Zr-Immuno-PET in Navigating and Derisking the Development of BiopharmaceuticalsGuus A M S van Dongen, Wissam Beaino, Albert D Windhorst, et al.
British Journal of Pharmacology|June 14, 2005
New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kineticsJoost Bart, Eli C F Dijkers, Theodora D Wegman, et al.
Acta Oncologica (Stockholm, Sweden)|March 26, 2019
Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patientsChristel C L M Boons, Vashti N M F Tromp, Nienke J M Neppelenbroek, et al.
Nuklearmedizin. Nuclear Medicine|July 23, 2016
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world studyRogier Lange, Floor Overbeek, John M H de Klerk, et al.
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital settingG Luurtsema, R Boellaard, H N J M Greuter, et al.
Journal of Neuro-Oncology|May 8, 2021
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine gliomaFatma E El-Khouly, Sophie E M Veldhuijzen van Zanten, Marc H A Jansen, et al.
EJNMMI Research|March 30, 2012
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoproteinFemke E Froklage, Stina Syvänen, N Harry Hendrikse, et al.
Pageof 10